Linezolid 600mg is a synthetic antibiotic belonging to the oxazolidinone class, used to treat serious bacterial infections, particularly those caused by Gram-positive bacteria. It works by inhibiting the bacterial protein synthesis by binding to the bacterial ribosome, preventing the formation of essential proteins for bacterial growth. Linezolid is typically prescribed for infections that are resistant to other antibiotics, such as vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA).

Common indications for Linezolid 600mg include the treatment of pneumonia, skin and soft tissue infections, bloodstream infections, and infections in patients with weakened immune systems. The usual dosing for Linezolid is 600mg twice daily, either as an intravenous infusion or an oral tablet, depending on the patient’s condition and healthcare setting.